TY  - GEN
AU  - Friedland,G H
AU  - Pollard,R
AU  - Griffith,B
AU  - Hughes,M
AU  - Morse,G
AU  - Bassett,R
AU  - Freimuth,W
AU  - Demeter,L
AU  - Connick,E
AU  - Nevin,T
AU  - Hirsch,M
AU  - Fischl,M
TI  - Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team
SN  - 1525-4135
PY  - 1999///0809
KW  - Adult
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - CD4 Lymphocyte Count
KW  - Delavirdine
KW  - Didanosine
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - isolation & purification
KW  - Humans
KW  - Male
KW  - RNA, Viral
KW  - blood
KW  - Reverse Transcriptase Inhibitors
KW  - Safety
KW  - Zidovudine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00126334-199908010-00005
ER  -